Unlocking the genomic and epigenetic variations that drive human health
Nooma Bio is developing a proprietary dual-nanopore technology that enables scientists to unlock the genome-wide structural and epigenetic variations that drive human health. Our core platform produces ultra high-resolution genome and epigenome maps by performing repetitive electronic scans of oligo-tagged DNA molecules in a matter of seconds. We are privately held and headquartered in Santa Cruz, Calif.
Kevin Corcoran, Chief Executive Officer
William Dunbar, PhD, Founder and Chief Technology Officer
Paul Lundquist, PhD, Senior Vice President of Engineering
Adrian Fehr, PhD, Vice President of Product Development